Next Article in Journal
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab
Previous Article in Journal
Prognostic Role of TAPSE to PASP Ratio in Patients Undergoing MitraClip Procedure
 
 
Article

Article Versions Notes

J. Clin. Med. 2021, 10(5), 1003; https://doi.org/10.3390/jcm10051003
Action Date Notes Link
article xml file uploaded 2 March 2021 11:16 CET Original file -
article xml uploaded. 2 March 2021 11:16 CET Update https://www.mdpi.com/2077-0383/10/5/1003/xml
article pdf uploaded. 2 March 2021 11:16 CET Version of Record https://www.mdpi.com/2077-0383/10/5/1003/pdf
article supplementary file uploaded. 2 March 2021 11:16 CET - https://www.mdpi.com/2077-0383/10/5/1003#supplementary
article html file updated 2 March 2021 11:17 CET Original file -
article html file updated 25 July 2022 05:44 CEST Update https://www.mdpi.com/2077-0383/10/5/1003/html
Back to TopTop